Divis Laboratories Ltd reported 58.35 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
Aurobindo Pharma 21.22 2.02 Mar/2026
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 58.35 1.4 Jun/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 21.45 2.08 Jun/2026
Lupin 22.82 5.32 Mar/2026
Moderna 27.22 14.51 Jun/2023
Organon & Co 8.32 4.57 Mar/2026
Revvity 36.47 5.68 Jun/2026
Tectonic Therapeutic 4.01 0.63 Mar/2024
Tilray 11.56 80.19 Sep/2025
Viatris 34.47 19.86 Jun/2026
Xeris Pharmaceuticals 76.05 2.37K Mar/2026